Skip to content

Intraocular Pressure After Preserflo / Innfocus Microshunt Implantation vs Trabeculectomy

Intraocular Pressure After Preserflo /Innfocus Microshunt vs Trabeculectomy: a Prospective, Randomised Control-trial (PAINT-Study)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04440527
Acronym
PAINT
Enrollment
70
Registered
2020-06-19
Start date
2020-07-22
Completion date
2024-07-22
Last updated
2020-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma

Brief summary

The aim of this project is to compare trabeculectomy with Preserflo / Innfocus Microshunt in patients with Primary Angle Open Glaucoma and Pseudoexfoliation Glaucoma regarding the reduction of intraocular pressure.

Detailed description

The study is a prospective, randomized, monocentric, part blinded, controlled non-inferiority study of glaucoma patients.

Interventions

DEVICEPreserflo / Innfocus Microshunt

The Microshunt features an 8.5-mm tube with an outer diameter of 350 µm and a 70-µm diameter lumen. Implantation creates a subconjunctival bleb and lowers intraocular pressure by increasing aqueous humor outflow.

OTHERTrabeculectomy

Trabeculectomy is the most commonly performed surgical procedure and is considered the gold standard.

Sponsors

Medical University Innsbruck
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Primary open angle glaucoma or pseudoexfoliation glaucoma * medically uncontrollable intraocular pressure or intolerance of topical therapy * negative urine/serum pregnancy test of women in childbearing age * signed and dated informed consent

Exclusion criteria

* previous incisional glaucoma procedure on affected eye * pregnancy, nursing period * Patients in military service, training periods and civil service * Participation in another clinical trail * pre-existing ocular pathologies: high myopia (refraction ≥8.00 D), thin conjunctiva

Design outcomes

Primary

MeasureTime frameDescription
Difference in intraocular pressure1 yearThe primary endpoint is the difference between intraocular pressure after microshunt implantation vs trabeculectomy.

Countries

Austria

Contacts

Primary ContactTeresa Rauchegger, Dr.
teresa.rauchegger@i-med.ac.at+43 512 504 24184
Backup ContactBarbara Teuchner, Dr.
barbara.teuchner@i-med.ac.at+43 512 504 24184

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026